Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Coronavirus vaccine
Took Part In Covishield, Covaxin Trials? Download Digital Certificates From These Apps
New Delhi: Those who participated in the clinical trials of Covishield and Covaxin, and actually got both vaccine doses can now access their certificates digitally.
The Union Ministry of Health & Family Welfare announced on Monday that…
ZyCOV-D Vaccine For 12-Plus: 1 Crore Doses A Month From Oct, Price Next Week
New Delhi: ZyCOV-D vaccine for adolescents above the age of 12 will be available in India next month.
The price of this new COVID-19 vaccine, which got emergency use approval a day earlier, will however be announced next week, Zydus Group…
Johnson & Johnson Applies For Vaccine Trial Among 12-17 Age Group In India
New Delhi: Johnson & Johnson (J & J) has applied to India’s Central Drugs Standard Control Organisation (CDSCO) for permission to conduct a study of its COVID vaccine Janssen among adolescents in this country aged 12-17 years.
In…
39 Million People Didn’t Get 2nd COVID Vaccine Shot In Stipulated Time, Reveals RTI
Nearly 39 million people in India did not receive their second dose of COVID-19 vaccine within the stipulated time.
This is according to the Union government’s response to a Right to Information (RTI) query filed by activist Raman Sharma,…
Nasal COVID Vaccine: Bharat Biotech Head Confident About Efficacy
Bharat Biotech’s top honcho is confident about the efficacy of the intra-nasal vaccine against COVID-19 that the Hyderabad-based company is developing.
Bharat Biotech’s Chairman and MD Dr Krisha Ella said on Sunday that the vaccine, which…
Serum Institute Founder Doesn’t Want Mixing Of COVID Vaccines; Know Why
Pune: Serum Institute of India (SII) founder and chairman Dr Cyrus Poonawalla is not in favour of mixing COVID-19 vaccines.
He is of the opinion that mixing could lead to a blame game between the drug manufacturers.
“I am against the…
Bharat Biotech’s Nasal COVID Vaccine Set For Phase 2/3 Trial
New Delhi: Bharat Biotech’s nasal vaccine to fight COVID-19 has been cleared by regulators for Phase 2/3 trial.
According to the Ministry of Science and Technology, the Phase 1 trial of the adenoviral intranasal vaccine BBV154 among…
Mixing Covaxin, Covishield Shows Better Results Than 2 Doses Of Same Vaccine: ICMR
New Delhi: Combining Covaxin and Covishield results in better immunogenicity than two doses of the same vaccine, the Indian Council of Medical Research (ICMR) has said.
The findings are based on a study conducted by Pune-based National…
Legal Protection Issue: Moderna, Pfizer Await India’s Decision
New Delhi: Pfizer and Moderna’s COVID-19 vaccines have reached neighbouring Pakistan, Bangladesh and Sri Lanka.
But their entry to India is still in limbo, as the Central government has not yet decided on whether to extend legal protection…
Covaxin’s Second Dose Trial For 2-6 Years Old Children To Start At AIIMS Delhi
New Delhi: The second dose trial of Bharat Biotech’s COVID-19 vaccine, Covaxin, for children between 2-6 years will begin at the All India Institute of Medical Sciences (AIIMS) in New Delhi next week.
According to news agency ANI, the…